Mushrooms Inc
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Kimberly Zawi Carlson
- Full Time Employees
- 6
- Sector
- Consumer Defensive
- Industry
- Agricultural Farm Products
- Address
- 23150 Fashion Drive Estero NV United States of America 33928
- IPO Date
- Nov 20, 2006
- CIK
- 0001334741
- Website
- mushroomsinc.com
- Similar Companies
- Business
- Mushrooms Inc specializes in sustainable biotechnology leveraging mycology, the science of mushrooms, to develop and manufacture industrial applications of mycelium hyphae. Its product portfolio includes mycelium-based bioplastics and packaging materials designed as carbon-neutral alternatives to traditional toxic plastics, as well as innovative health supplements such as LONGEVITY and SPORT+. The company pioneers mycelium-based performance textiles under the MYCOthread brand, which integrates transdermal nutrient delivery into fabrics for athletic wear. Mushrooms Inc operates globally with a focus on environmentally conscious manufacturing and healthcare innovation. Founded in 2002 and headquartered in Estero, Florida, the company underwent a significant strategic rebranding, changing its name from Marijuana Strategic Ventures Inc. to Mushrooms Inc. in 2022. Recent developments include filing a provisional patent application for its mycelium thread technology and forming a business development team to drive growth and innovation, alongside expanding its collaboration with a renowned scientific team in Germany to advance product development. The company also pursues a strategy of acquiring and merging with companies focused on the mushroom industry to expand its market presence and product offerings. Mushrooms Inc trades under the ticker MSRM on the OTC market.
Mushrooms Inc. (OTC: MSRM) Achieves Proof of Concept for MycoLabX Infection-Detection Technology and Provides Strategic Update
Mushrooms Inc. (OTC: MSRM) Achieves Proof of Concept for MycoLabX Infection-Detection Technology and Provides Strategic Update
Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise
Mushrooms, Inc. (OTC: MSRM) Signs Share Exchange Agreement to Acquire SecurCapital Corp
Mushrooms, Inc. (OTC: MSRM) Signs Share Exchange Agreement to Acquire SecurCapital Corp
Laird Superfood® Brews New Fall Flavor: Maple Instant Latte with Functional Mushrooms
Hypha Labs Expands List of Functional Mushrooms Able to be Produced in its Revolutionary Mushroom Accelerator
KBRA Assigns Preliminary Ratings to Morgan Stanley Residential Mortgage Loan Trust 2025-HX1 (MSRM 2025-HX1)
Hypha Laboratories Applauds Call for Regulatory Changes for Functional Mushrooms
Emerging Markets Report: A Mushroom Monster in the Making
Announcing Adaptin - Bringing Mushrooms to the Masses
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives
Mushrooms Inc. (OTC:MSRM) Launches New Health Supplements, Progresses with German Partnership, and Boosts Engagement Initiatives
Mushrooms Inc. Discusses Utility Patent Filing For MYCO Thread Applications on The Stock Day Podcast
Mushrooms Inc. (OTC:MSRM) expands on full patent filing for Nutrient-Delivery Textile Innovation, MYCOThread
Mushrooms, Inc. (OTC: MSRM) Announces Diverse Business Development Team Assembled to Drive Company Growth
Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast
Time to Buy the Magic Stocks? Magic Mushrooms, That Is.